Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ilaprazole for GERD
NCT01107938Phase 2Unknown
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- May 2010
- Primary completion
- Jun 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ilaprazole in erosive esophagitis (EE), gastroesophageal reflux disease (GERD), sponsored by Livzon Pharmaceutical Group Inc.. Status: unknown.
02
Drugs
ilaprazole
03
Conditions
erosive esophagitis (EE)gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01107938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01107938.